Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

4.50
-0.1000-2.17%
Post-market: 4.500.00000.00%17:01 EDT
Volume:2.53M
Turnover:11.24M
Market Cap:508.77M
PE:-0.99
High:4.54
Open:4.51
Low:4.31
Close:4.60
52wk High:10.08
52wk Low:2.10
Shares:113.06M
Float Shares:94.15M
Volume Ratio:1.03
T/O Rate:2.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5419
EPS(LYR):-5.0732
ROE:-66.97%
ROA:-0.78%
PB:1.33
PE(LYR):-0.89

Loading ...

Evolent Health President Daniel Joseph McCarthy Sells 65,892 Shares for $329,460

Reuters
·
Aug 29

Humana Names Shantanu Nundy Chief Medical Officer Effective Aug. 31

Reuters
·
Aug 20

Evolent Health Price Target Cut to $6.00/Share from $7.00 by Truist Securities

Dow Jones
·
Aug 13

Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH)

TIPRANKS
·
Aug 12

Evolent Health Shares Rise After Citigroup Upgrade

MT Newswires Live
·
Aug 12

Citigroup Upgrades Evolent Health to Buy From Neutral, Adjusts PT to $6 From $6.75

MT Newswires Live
·
Aug 11

Evolent Health Price Target Cut to $6.00/Share from $7.00 by Canaccord Genuity

Dow Jones
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Evolent Health Earnings Call Balances Growth and Risk

TIPRANKS
·
Aug 10

Evolent Health (EVH) Stock Rebounds As Growth Momentum Confronts Losses

Simply Wall St.
·
Aug 08

Evolent Health: Buy Rating Reiterated as Strong Contracts and Enhanced Risk Protections Support Growth; $5 Price Target Maintained

TIPRANKS
·
Aug 07

Progyny Q2 Revenue Rises 5%, Slightly Beats Estimates

Reuters
·
Aug 07

Evolent Health: Improving Fundamentals, Raised Long‑Term Guidance and Strong Contract Pipeline Support Buy Rating

TIPRANKS
·
Aug 07

Evolent Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Evolent Q2 2026 Earnings: Revenue Growth Came With Margin Pressure

TradingKey
·
Aug 06

Evolent Q2 FY26 Net Loss Narrows to $28.36 Million; Revenue Rises 46.84% to $652.52 Million

Reuters
·
Aug 06

Evolent Health Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $652.520M Beat $597.997M Estimate

Benzinga Earnings
·
Aug 06

Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million

Reuters
·
Aug 06

Evolent Health, - Raises 2026 Revenue Guidance to $2.6-$2.70 Bln

THOMSON REUTERS
·
Aug 06

Evolent Health, - Expects 2027 Revenue Growth over 25% Compared to 2026 and Adj Ebitda Midpoint at or Above $150 Mln

THOMSON REUTERS
·
Aug 06